Cargando…
The effects of IL-17/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: A protocol for systematic review and meta analysis
BACKGROUND: Psoriasis (PSO) is a systemic inflammatory disorder that presents with erythematous scaling of the skin and is associated with autoimmune dysfunction. Atherosclerosis is one of the major comorbidities of PSO. PSO-associated inflammatory factor IL-17 could lead to vascular endothelial cel...
Autores principales: | Liu, Ningyuan, Su, Danni, Liu, Keshuai, Liu, Binbin, Wang, Shibo, Zhang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886472/ https://www.ncbi.nlm.nih.gov/pubmed/33578549 http://dx.doi.org/10.1097/MD.0000000000024549 |
Ejemplares similares
-
The association between biologic agents and the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: A protocol for a systematic review and meta-analysis
por: Ma, Jie, et al.
Publicado: (2019) -
Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis
por: Zou, Ailing, et al.
Publicado: (2021) -
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018) -
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
por: Tsiogka, Aikaterini, et al.
Publicado: (2023) -
Association Between Psoriasis and Subclinical Atherosclerosis: A Meta-Analysis
por: Fang, Na, et al.
Publicado: (2016)